Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Eusynthomycin
2. Madomicetina
3. Levomycetin Stearate
4. 16255-48-4
5. Dl2a9m9d6x
6. Chloroamphenicol Stearate
7. Chloramphenicol Monostearate
8. (2r,3r)-2-(2,2-dichloroacetamido)-3-hydroxy-3-(4-nitrophenyl)propyl Stearate
9. Chloroamphenicol Stearic Acid Ester
10. Einecs 240-363-4
11. Unii-dl2a9m9d6x
12. Brn 2797487
13. Stearic Acid, Ester With Chloramphenicol
14. Quemicetina (tn)
15. 2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide Alpha-stearate
16. 4-13-00-02754 (beilstein Handbook Reference)
17. Octadecanoic Acid, 2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl Ester, (r-(r*,r*))-
18. Schembl10791882
19. Dtxsid20167407
20. Chebi:177426
21. Zinc8214522
22. (-)-chloramphenicol Stearate
23. Akos005267198
24. (r-(r*,r*))-2-((dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl Stearate
25. [(2r,3r)-2-[(2,2-dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl] Octadecanoate
26. Chloramphenicol Stearate [who-dd]
27. Chloramphenicol Stearic Acid Ester
28. Octadecanoic Acid, (2r,3r)-2-((dichloroacetyl)amino)-3-hydrdoxy-3-(4-nitrophenyl)propyl Ester
29. Stearic Acid, Alpha-ester With D-threo-(-)-2,2-dichloro-n-(beta-hydroxy-alpha-(hydroxymethyl)-p-nitrophenethyl)acetamide
30. D07674
31. Q27276455
32. (2r,3r)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Stearate
33. Octadecanoic Acid (2r,3r)-2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl Ester
34. Octadecanoic Acid, (2r,3r)-2-((2,2-dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propyl Ester
| Molecular Weight | 589.6 g/mol |
|---|---|
| Molecular Formula | C29H46Cl2N2O6 |
| XLogP3 | 10.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 23 |
| Exact Mass | 588.2732926 g/mol |
| Monoisotopic Mass | 588.2732926 g/mol |
| Topological Polar Surface Area | 121 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 669 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Eusynthomycin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Eusynthomycin, including repackagers and relabelers. The FDA regulates Eusynthomycin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Eusynthomycin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Eusynthomycin supplier is an individual or a company that provides Eusynthomycin active pharmaceutical ingredient (API) or Eusynthomycin finished formulations upon request. The Eusynthomycin suppliers may include Eusynthomycin API manufacturers, exporters, distributors and traders.
Eusynthomycin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Eusynthomycin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Eusynthomycin GMP manufacturer or Eusynthomycin GMP API supplier for your needs.
A Eusynthomycin CoA (Certificate of Analysis) is a formal document that attests to Eusynthomycin's compliance with Eusynthomycin specifications and serves as a tool for batch-level quality control.
Eusynthomycin CoA mostly includes findings from lab analyses of a specific batch. For each Eusynthomycin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Eusynthomycin may be tested according to a variety of international standards, such as European Pharmacopoeia (Eusynthomycin EP), Eusynthomycin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Eusynthomycin USP).
LOOKING FOR A SUPPLIER?
